| Literature DB >> 35292616 |
Zhongzhi Zhou1, Li Chen2,3, Yuxin Su4, Meirong Li3, Lingzhi Zhong3, Liangying Liao1, Yarong Ding2, Mulin Liu2, Zhonghang Yuan2, Wei Wang2, Xinyu Hang2, Xiuna Fang2, Xiaobing Fu3, Wenjun He3, Qian Hou3.
Abstract
BACKGROUND Wound healing is a dynamic and complex process that is regulated by a variety of factors and pathways. This study sought to identify the mechanisms of the four-herb Chinese medicine ANBP in enhancing wound repair. MATERIAL AND METHODS By comparing the group treated with ANBP for 6 h (Z6h) with the corresponding control group (C6h), we used the new high-throughput differential acetylation proteomics method to explore the mechanism of ANBP treatment and analyse and identify new targets of ANBP for promoting wound healing. RESULTS ANBP promoted skin wound healing in mice; the wound healing process was accelerated and the wound healing time was shortened (P<0.05). The upregulated proteins were distributed mostly in the mitochondria to nuclear respiratory chain complexes and cytoplasmic vesicles. The dominant pathways for upregulated proteins were fatty acid metabolism, pyruvate metabolism, and tricarboxylic acid cycle. Pdha1 was upregulated with the most acetylation sites, while the downregulated Ncl, and Pfkm were most acetylated. CONCLUSIONS The findings from our study showed that ANBP improved cell aerobic respiration through enhanced glycolysis, pyruvic acid oxidative decarboxylation, and the Krebs cycle to produce more ATP for energy consumption, thus accelerating wound repair of skin.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35292616 PMCID: PMC8935859 DOI: 10.12659/MSM.934816
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Effect of ANBP on wound healing. (A) Skin wound healing of mice in the ANBP treatment group and the control group at 6 h, 3 d, 7 d and 14 d after wounding. (B) Wound healing rate in the ANBP treatment group and the control group. The wound healing rate of the ANBP treatment group and the control group. Percentage wound healing = (initial wound size – current wound size) ÷ initial wound size ×100%.
Figure 2Workflow for the quantitative acetylome and proteome based on TMT. Three replicates of the global proteome and acetylated proteome were performed in the ANBP treatment group and the control group.
Comprehensive profiling of the global and acetylated proteomes.
| Profiling names | Identification | Quantification |
|---|---|---|
| Global proteins | 3238 | 2581 |
| Acetylated proteins | 485 | 449 |
| Acetylated sites | 1032 | 948 |
Number of differentially quantified proteins by comparing ANBP-treated mice with the control.
| Group comparison | Type | Global proteins | Acetyl proteins | ||
|---|---|---|---|---|---|
| Upregulated (>1.2) | Downregulated (<1/1.2) | Upregulated (>1.2) | Downregulated (<1/1.2) | ||
| Z6h/C6h | Sites | 101 | 282 | 110 | 45 |
| Proteins | 86 | 31 | |||
Z6h/C6h, the comparison of the ANBP treatment group and the control group; P<0.05.
The feature sequence around acetylated sites by motif analysis.
| Motif | Motif score | Foreground | Background | Fold increase | ||
|---|---|---|---|---|---|---|
| Matches | Size | Matches | Size | |||
| ..........KK......... | 16 | 188 | 970 | 40370 | 508259 | 2.44 |
| ..........KH......... | 16 | 84 | 782 | 12293 | 467889 | 4.09 |
| ..........KN......... | 13.13 | 80 | 698 | 20661 | 455596 | 2.53 |
| ..........KR......... | 13.22 | 95 | 618 | 29172 | 434935 | 2.29 |
| ..........K.......K.. | 10.38 | 82 | 523 | 29319 | 405763 | 2.17 |
| ..........K....K..... | 7.89 | 66 | 441 | 26907 | 376444 | 2.09 |
| ..........K...K...... | 7.81 | 58 | 375 | 24530 | 349537 | 2.2 |
Figure 3Lysine acetylation preferences for significantly changed acetylation sites. Red represents a significant concentration of this amino acid close to the modification site, while green represents a significant reduction in secondary amino acids close to the modification site.
GO annotation for upregulated and downregulated acetylated proteins.
| GO terms level 1 | GO terms level 2 | No. of upregulated acetylated proteins | No. of downregulated acetylated proteins |
|---|---|---|---|
|
| Cellular process | 78 | 28 |
| Single-organism process | 71 | 24 | |
| Metabolic process | 56 | 17 | |
| Biological regulation | 54 | 21 | |
| Multicellular organismal process | 49 | 21 | |
| Response to stimulus | 44 | 20 | |
| Developmental process | 39 | 15 | |
|
| Organelle | 86 | 27 |
| Cell | 85 | 30 | |
| Extracellular region | 63 | 24 | |
| Macromolecular complex | 51 | 18 | |
| Membrane | 50 | 13 | |
|
| Binding | 75 | 31 |
| Catalytic activity | 43 | 12 | |
| Structural molecule activity | 15 | 3 | |
| Transporter activity | 7 | 3 |
Figure 4Distribution of subcellular location for upregulated and downregulated proteins. (A) Upregulated protein subcellular location in Z6h/C6h; (B) downregulated protein subcellular location in Z6h/C6h.
Figure 5Classification of differentially acetylated sites and heatmap of clustering analysis based on GO enrichment. (A) Classification of differentially acetylated sites Q1, Q2, Q3 and Q4. (B) Heatmap of biological processes for the 4 groups of differentially acetylated sites. (C) Heatmap of cellular components for the 4 groups of differentially acetylated sites. (D) Heatmap of molecular functions for the 4 groups of differentially acetylated sites.
Figure 6Heatmap of clustering analysis based on KEGG pathways and protein domains. (A) Heatmap of KEGG pathways for the 4 groups of differentially acetylated sites. (B) Heatmap of protein domains for the 4 groups of differentially acetylated sites.
Figure 7Protein–protein interaction network of acetylated proteins in periposine-treated AS cells.